cooper finish fiscal strong increas fve due
favor outlook len market
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research dec
estim aug
price data dec
rate updat dec
currenc amount express
methodolog valu compani
report solid fourth-quart result revenu
last year million bring full-
year revenu billion increas last
year constant currenc trade-up trend daili
silicon hydrogel show sign slow
firm share daili market still under-penetrated
indic room grow global addit
paragard perform well driven sustain margin
improv surgic effect slightli
off-set increas sale market spend cooper
continu hire sale rep invest asia-pacif
region capit expenditur larg due expand
manufactur line steadi uptak daili lens
like rais fair valu estim revisit
long-term assumpt segment
maintain narrow moat due strong
len portfolio continu pick share global
expect fiscal sit higher end
manag new guidanc billion vision
revenu million surgic revenu
cooper vision toric lens daili continu drive
growth last year constant
currenc respect toric daili also drove
growth america revenu healthi
follow launch myday toric earlier year
asia-pacif region continu post double-digit
increas contribut firm revenu
call manag express confid
continu see double-digit increas asia
fourth quarter top line healthi cooper
vision gross margin came lower anticip
compar adjust basi last year
declin mostli currenc headwind
also affect higher ship distribut
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
cooper compani oper two unit coopervis coopersurg
account total sale coopervis one world
top four develop manufactur contact lens
coopervis sale intern territori second unit
coopersurg develop manufactur diagnost surgic
product gynecologist obstetrician
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
cost write-off legaci hydrogel lens expect
pressur distribut cost continu
near term focus deliv high-qual
servic premier ship especi len
subscript program gain traction expect
inventori write-off result better-than-expect uptak
silicon hydrogel impact fiscal
cooper surgic contribut million
one fourth firm total revenu led
paragard offset weak fertil
genom busi paragard boost segment
fourth-quart gross margin compar
adjust basi last year offic surgic product
outsid paragard perform well increas
manag attribut quarter paragard
growth channel inventori expans firm focus
market campaign pay firm hire new sale
rep paragard bring salesforc
product post strong growth fiscal
note also invest heavili sale
market effort expect continu
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end octob
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end octob
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
